Clinical Trials & Medical Research

Clinical trials are the gold standard for validating cannabis-based medicines, and this sub-category tracks every significant study from early-phase safety trials to pivotal Phase III results. Hemp Gazette reports on trials investigating cannabinoids for conditions including treatment-resistant epilepsy, Fragile X syndrome, chronic insomnia, chemotherapy-induced nausea, and neuropathic pain — covering primary endpoints, adverse event profiles, regulatory submissions, and the biotech companies sponsoring the research.

Beyond individual trial updates, we contextualise the broader medical research landscape: systematic reviews, meta-analyses, observational studies, and real-world evidence data that are collectively reshaping how regulators, physicians, and insurers evaluate cannabinoid medicines. If you follow cannabis science, this is where the peer-reviewed evidence lives.